Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TrueBlue (TBI) Asset Writedowns and Impairment (2016 - 2025)

TrueBlue (TBI) has disclosed Asset Writedowns and Impairment for 17 consecutive years, with $2.4 million as the latest value for Q4 2025.

  • On a quarterly basis, Asset Writedowns and Impairment rose 250.67% to $2.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.8 million, a 95.27% decrease, with the full-year FY2025 number at $2.8 million, changed N/A from a year prior.
  • Asset Writedowns and Impairment was $2.4 million for Q4 2025 at TrueBlue, up from $185000.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $59.7 million in Q2 2024 to a low of -$3.4 million in Q4 2022.
  • A 5-year average of $4.6 million and a median of $947000.0 in 2024 define the central range for Asset Writedowns and Impairment.
  • Peak YoY movement for Asset Writedowns and Impairment: surged 32736.36% in 2021, then tumbled 10613.33% in 2024.
  • TrueBlue's Asset Writedowns and Impairment stood at $3.6 million in 2021, then tumbled by 192.8% to -$3.4 million in 2022, then surged by 100.45% to $15000.0 in 2023, then crashed by 10613.33% to -$1.6 million in 2024, then soared by 250.67% to $2.4 million in 2025.
  • Per Business Quant, the three most recent readings for TBI's Asset Writedowns and Impairment are $2.4 million (Q4 2025), $185000.0 (Q2 2025), and $250000.0 (Q1 2025).